MiMedx Group, Inc (MDXG) vs Prime Medicine, Inc. (PRME)
- MiMedx Group, Inc MDXG 4.43 −5.34%
- Prime Medicine, Inc. PRME 3.47 −3.88%
MiMedx Group, Inc and Prime Medicine, Inc. are both Biotechnology companies. MiMedx Group, Inc and Prime Medicine, Inc. are of similar size ($682.2M and $654.8M). Prime Medicine, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 111×. MiMedx Group, Inc grew revenue faster over the last twelve months: −2.36% against −17.9%. MiMedx Group, Inc has the higher net margin (1.76% vs −4,613.1%) and the higher return on invested capital (5.62% vs 0.00%). Across the 17 metrics below, MiMedx Group, Inc leads on 14 and Prime Medicine, Inc. on 3.
Valuation
Profitability
| Metric | MDXG | PRME | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.85% | 100.00% | 65.16% |
| Operating margin | 2.46% | (4,824.94%) | 0.00% |
| Net margin | 1.76% | (4,613.11%) | 0.00% |
| Free cash flow margin | 12.51% | (3,850.92%) | 0.00% |
| Return on equity | 2.88% | (373.29%) | (56.36%) |
| Return on assets | 2.18% | (71.16%) | (48.04%) |
| Return on invested capital | 5.62% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack